Avidity NanoMedicines Receives $6,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dc3d8211-9c9b-4902-9f50-eb3c0f5d4d5d
Date
10/8/2014
Company Name
Avidity NanoMedicines
Mailing Address
11119 North Torrey Pines Road La Jolla, CA 92037 USA
Company Description
Avidity NanoMedicines is advancing a new class of drug candidates, antibody-siRNA complexes (ARCs™), which draw on the best features of both antibody-drug conjugates and nucleic acid-based medicines and which utilize nano-scale self-assembly to create a transformative approach to the treatment of cancer and other serious diseases.
Website
http://www.aviditynano.com
Transaction Type
Venture Equity
Transaction Amount
$6,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds from the financing will be used to advance new cancer therapies that utilize the company’s proprietary antibody-siRNA complex (ARC™) platform.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor